Open AccessRandomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904
Author(s) -
Matthew H. Kulke,
Margaret A. Tempero,
Doniedzwiecki,
Donna Hollis,
Hedy L. Kindler,
Michael Cusnir,
Peter C. Enzinger,
Stefan M. Gorsch,
Richard M. Goldberg,
Robert J. Mayer
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/894b-gr11
Subject(s) - irinotecan , gemcitabine , docetaxel , medicine , cisplatin , oncology , pancreatic cancer , randomized controlled trial , chemotherapy , cancer , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom